Blood gas and electrolyte analyzers are gaining popularity as the most versatile diagnostic devices globally. Blood gas analyzer measures partial pressure of oxygen in a patient’s body, while electrolyte analyzer measures concentration of vital elements such as sodium, potassium, and calcium among others. Blood gas and electrolyte analyzer results, in combination with other tests have helped in accurate diagnosis of various chronic conditions such as asthma, chronic obstructive pulmonary disease (COPD), kidney failure, heart failure, uncontrolled diabetes, severe infections, and drug overdose.
Request a Sample Copy of the Report @ http://www.mrrse.com/sample/1569
Blood gas and electrolyte analyzers have been evolving from single parameter analyzer table-top devices, to rapid multiple analyte measuring compact point-of-care devices. These devices are widely used in intensive care units (ICUs), emergency medical services, and routine disease diagnosis. The global blood gas and electrolyte analyzer market was valued at US$ 1,437.5 Mn in 2014 and is projected to reach US$ 3,480.3 Mn in 2023 at a CAGR of 9.66% from 2015 to 2023. Currently, the market for devices with narrow analysis profile is in early maturity phase and is being gradually replaced by devices with wider analyte profile. Although demand for handheld devices is increasing rapidly, these devices would not completely replace traditional table-top devices. Combination analyzer market was estimated to be the fastest growing market segment, and also accounted for largest market share in 2014.
Inquiry on this report @ http://www.mrrse.com/enquiry/1569
New technology blood gas and electrolyte analyzers are also armed with wireless connectivity for integration with other hospital management software. This has helped in minimizing errors and save time and efforts. Discovery of novel biomarkers is expected to further expand the scope of application of blood gas analyzers in the near future. Simplified operation enabling non-medical personnel to perform critical diagnosis in shortest possible time is another factor driving the global blood gas and electrolyte market. Increasing prevalence of diseases and alarming loss of human capital due to aging population has raised serious health concerns across all nations. Obesity is also a prime predisposing factor for cardiovascular diseases, arthritis, and diabetes, among others. Hence, governments are encouraging innovation in medical technology to curb this crisis.
Read Complete Report with TOC @ http://www.mrrse.com/blood-gas-electrolyte-analyzers
Geographically, North America and Europe account for largest share of over 60% of the global blood gas and electrolyte analyzer market. These regions are currently experiencing a shift from single parameter analyzers to multiple parameter analyzers. Developing hospital infrastructure and subsequent integration of blood gas analyzers with hospital management software owing to changes in government policies has helped the market grow in these regions.
Key players in the market include Abbott Point of Care Inc., Alere, Inc., Erba Mannheim, Instrumentation Laboratory, Medica Corporation, Nova Biomedical, Radiometer Medical ApS, Roche Diagnostics, and Siemens Healthcare.
90 State Street,
Albany NY – 12207